I was thinking the same thing knowing that J&J bought recently another company in early preclinical for $1.7 billions and our friend from GSK can get a bidding war started for us
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.